All news from Anaesthesiology

Soaking in Hot Tub Could Boost Health for Obese Women With PCOS

Obese women with polycystic ovary syndrome (PCOS) may be able to improve their health through regular sessions in a hot tub, a study from University of Oregon reports. According to the research, soaking in a hot tub several times per week for two months results in improved cardiovascular health, beneficial changes in fat tissue and other improvements suggestive of a reduced risk of diabetes or other metabolic disorders.

Exercise May Help Make Heart Younger

In a new study researchers uncovered one explanation for why exercise might be beneficial: It stimulates the heart to make new muscle cells, both under normal conditions and after a heart attack. The findings, reported in Nature Communications, have implications for public health, physical education and the rehabilitation of cardiac patients.

New Study Demonstrating Efficacy and Safety of COPAXONE 40 mg/mL

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE® (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).

Bacteria Boost Antifungal Drug Resistance in Severe Childhood Caries

A new study from the University of Pennsylvania found that early childhood caries result from dental plaque that contains both bacteria and fungus working together to make the biofilm on the teeth more pathogenic and difficult to remove. Now they have shown that these two types of microorganisms synergize to enhance drug resistance, enabling the fungal cells to avoid being killed by antifungal therapies. Yet simultaneously targeting the matrix produced by the bacteria along with the fungus offers a way around this protection.

MS Drug Could Reduce Painful Side Effects of Common Cancer Therapy

Researchers from the Saint Louis University School of Medicine have discovered why many cancer patients experience severe pain when treated with the anticancer drug bortezomib. The study, to be published in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing myeloma patients to successfully complete their treatment and relieving the pain of myeloma survivors.